1. Home
  2. ALNT vs ERAS Comparison

ALNT vs ERAS Comparison

Compare ALNT & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allient Inc.

ALNT

Allient Inc.

HOLD

Current Price

$62.34

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Logo Erasca Inc.

ERAS

Erasca Inc.

HOLD

Current Price

$13.62

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALNT
ERAS
Founded
1962
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
ALNT
ERAS
Price
$62.34
$13.62
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$58.00
$7.20
AVG Volume (30 Days)
169.4K
3.5M
Earning Date
01-01-0001
06-22-2026
Dividend Yield
0.19%
N/A
EPS Growth
67.09
36.23
EPS
1.32
N/A
Revenue
$554,478,000.00
N/A
Revenue This Year
$5.57
N/A
Revenue Next Year
$6.66
N/A
P/E Ratio
$48.39
N/A
Revenue Growth
4.62
N/A
52 Week Low
$19.25
$1.01
52 Week High
$70.00
$16.14

Technical Indicators

Market Signals
Indicator
ALNT
ERAS
Relative Strength Index (RSI) 46.18 54.25
Support Level $51.88 $1.46
Resistance Level $68.30 N/A
Average True Range (ATR) 3.85 1.02
MACD -0.42 -0.20
Stochastic Oscillator 53.27 26.21

Price Performance

Historical Comparison
ALNT
ERAS

About ALNT Allient Inc.

Allient Inc, formerly Allied Motion Technologies Inc designs, manufactures, and sells precision and specialty motion control components and systems. The firm primarily caters to the vehicle, medical, aerospace and defense, and electronics and industrial, pumps, and robotics sectors. It mainly operates and sells across the United States, Canada, South America, Europe, and Asia. Its products and solutions include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues.

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.

Share on Social Networks: